The Cellular and Architectural Determinants of Immune Evasion and Their Impact on Response to Therapy in Classical Hodgkin Lymphoma


IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Margaret A. Shipp, MD, Dana-Farber Cancer Institute/ Harvard Medical School

Dr. Shipp is mapping the immune microenvironment in classical Hodgkin lymphoma.

BACK TO OUR PORTFOLIO